Friday, September 5, 2014

Fosun Pharma to Invest $46.2 million in Nature's Sunshine

Nature's Sunshine Products, Inc., a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, announced the closing of its China joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and private placement transaction of 2.854 million shares of common stock, representing approximately 15% of Nature's Sunshine's outstanding common shares, to Fosun Pharma at a price of $16.19 per share. Aggregate proceeds to Nature's Sunshine were approximately $46.2 million.

The joint venture, known as Nature's Sunshine Hong Kong Limited, is 80% owned by Nature's Sunshine and 20% owned by a wholly-owned subsidiary of Fosun Pharma.

Shanghai Fosun Pharmaceutical is a leading listed company in China's pharmaceutical industry and was listed on Shanghai Stock Exchange in August 1998 and on the Main Board of the Stock Exchange of Hong Kong Limited in October 2012. Its main business includes pharmaceutical manufacturing, distribution and retail; healthcare services; diagnostic products and medical device. 

In May 2013 Fosun Pharma bought Israeli company Alma Lasers for $240 million. 

No comments:

Post a Comment